Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases
AssigneeMerck Frosst Canada, Inc.
InventorsYves Ducharme, Jacques Yves Gauthier, Petpiboon Prasit, Yves Leblanc, Zhaoyin Wang, Serge Leger, Michel Therien
Life of this patent
Estimating the term…
Abstract
The present invention provides a method of treating a neurodegenerative disease and in particular Alzheimers disease which comprises administering to a human in need thereof a therapeutically effective amount of a non-steroid COX-II inhibitor. Although a wide range of COX-II inhibitors may be employed but it is preferred to employ compounds of the Formula I:
Claims6
A method of treating pre-senile dementia associated with Alzheimer's disease in a human in need of such treatment which comprises administering to said human an effective amount of a non-steroidal COX-2 inhibitor, wherein said non-steroidal COX-2 inhibitor will bind at least 100 times as well to COX-2 as to COX-1.
A method of treating senile dementia in a human in need of such treatment which comprises administering to said human an effective amount of a non-steroidal COX-2 inhibitor, wherein said non-steroidal COX-2 inhibitor will bind at least 100 times as well to COX-2 as to COX-1.
Dependencies are inferred from the claim text.